tiprankstipranks
Advertisement
Advertisement
Nippon Shinyaku’s Promising DMD Study: What Investors Need to Know
PremiumCompany AnnouncementsNippon Shinyaku’s Promising DMD Study: What Investors Need to Know
5M ago
Nippon Shinyaku’s Promising Phase 2 Study for Duchenne Muscular Dystrophy
Premium
Company Announcements
Nippon Shinyaku’s Promising Phase 2 Study for Duchenne Muscular Dystrophy
5M ago
Nippon Shinyaku’s Promising Phase 2 Trial for Autoimmune Treatment
Premium
Company Announcements
Nippon Shinyaku’s Promising Phase 2 Trial for Autoimmune Treatment
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100